The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
Abstract
Purpose: Preoperative chemotherapy is an accepted standard in the treatment of localized esophagogastric adenocarcinoma. Adding radiation therapy to preoperative chemotherapy appears promising, but its definitive value remains unknown. Patients and Methods: Patients with locally advanced (uT3-4NXM0) adenocarcinoma of the lower esophagus or gastric cardia were randomly allocated to one of two treatment groups: induction chemotherapy (15 weeks) followed by surgery (arm A); or chemotherapy (12 weeks) followed by chemoradiotherapy (3 weeks) followed by surgery (arm B). Primary outcome was overall survival time. A total of 354 patients were needed to detect a 10% increase in 3-year survival from 25% to 35% by addition of radiation therapy. The study was prematurely closed due to low accrual. Results: The median observation time was 46 months. A total of 126 patients were randomly assigned and 119 eligible patients were evaluated. The number of patients undergoing complete tumor resection was not different between treatment groups (69.5% v 71.5%). Patients in arm B had a significant higher probability of showing pathologic complete response (15.6% v 2.0%) or tumor-free lymph nodes (64.4% v 37.7%) at resection. Preoperative radiation therapy improved 3-year survival rate from 27.7% to 47.4% (log-rank P = .07, hazard ratio adjusted for randomization strata variables 0.67, 95% CI, 0.41 to 1.07). Postoperative mortality was nonsignificantly increased in the chemoradiotherapy group (10.2% v 3.8%; P = .26). Conclusion: Although the study was closed early and statistical significance was not achieved, results point to a survival advantage for preoperative chemoradiotherapy compared with preoperative chemotherapy in adenocarcinomas of the esophagogastric junction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J. H., Nicolson, M., Scarffe, J. H., Lofts, F. J., Falk, S. J., Iveson, T. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055531 · Cited by 6,334
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Macdonald, J. S., Smalley, S. R., Benedetti, J., Hundahl, S. A., Estes, N. C., Stemmermann, G. N., Haller, D. G., Ajani, J. A., Gunderson, L. L., Jessup, J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010187 · Cited by 3,475
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
Walsh, T. N., Noonan, N., Hollywood, D., Kelly, A., Keeling, N., & Hennessy, T. P. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350702 · Cited by 1,950
(2002) · The Lancet · doi:10.1016/s0140-6736(02)08651-8 · Cited by 1,459
Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer
Kelsen, D. P., Ginsberg, R., Pajak, T. F., Sheahan, D. G., Gunderson, L., Mortimer, J., Estes, N., Haller, D. G., Ajani, J., Kocha, W., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392704 · Cited by 1,343
Urba, S. G., Orringer, M. B., Turrisi, A., Iannettoni, M., Forastiere, A., & Strawderman, M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.305 · Cited by 1,266
TNM classification of malignant tumours
Cassoni, A. M. (1998) · Clinical Oncology · doi:10.1016/s0936-6555(98)80120-9 · Cited by 1,191
Gebski, V., Burmeister, B., Smithers, B. M., Foo, K., Zalcberg, J., & Simes, J. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70039-6 · Cited by 1,158
Evaluation of Experiments with Adaptive Interim Analyses
Bauer, P., & Kohne, K. (1994) · Biometrics · doi:10.2307/2533441 · Cited by 865
Urschel, J. D., & Vasan, H. (2003) · The American Journal of Surgery · doi:10.1016/s0002-9610(03)00066-7 · Cited by 737
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis
Fiorica, F., Di Bona, D., Schepis, F., Licata, A., Shahied, L., Venturi, A., Falchi, A. M., Craxì, A., & Cammà, C. (2004) · Gut · doi:10.1136/gut.2003.025080 · Cited by 539
Siewert, J. R., Stein, H. J., Feith, M., Bruecher, B. L. D. M., Bartels, H., & Fink, U. (2001) · Annals of Surgery · doi:10.1097/00000658-200109000-00010 · Cited by 525
Postoperative mortality following oesophagectomy and problems in reporting its rate
Jamieson, G. G., Mathew, G., Ludemann, R., Wayman, J., Myers, J. C., & Devitt, P. G. (2004) · British Journal of Surgery · doi:10.1002/bjs.4596 · Cited by 271
Chemotherapy in gastric cancer: a review and updated meta-analysis
Janunger, K.-G., Hafström, L., & Glimelius, B. (2002) · The European Journal of Surgery · doi:10.1080/11024150201680005 · Cited by 224
Chirieac, L. R., Swisher, S. G., Correa, A. M., Ajani, J. A., Komaki, R. R., Rashid, A., Hamilton, S. R., & Wu, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1840 · Cited by 81
Lutz, M. P., Wilke, H., Wagener, D. J. T., Vanhoefer, U. J., Jeziorski, K., Hegewisch‐Becker, S., Balleisen, L., Joosens, E., Jansen, R. L., Debois, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.1666 · Cited by 69
Self-citationExclusive radical surgery for esophageal adenocarcinoma
Collard, J.-M. (2001) · Cancer · doi:10.1002/1097-0142(20010315)91:6<1098::aid-cncr1105>3.0.co;2-n · Cited by 62
Stahl, M., Vanhoefer, U. J., Stuschke, M., Walz, M. K., Müller, C., & Wilke, H. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10109-5 · Cited by 27
Self-citationCancer of the Gastroesophageal Junction: Combined Modality Therapy
Ilson, D. H. (2006) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2006.07.011 · Cited by 20
Cited by
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
van Hagen, P., Hulshof, M. C. C. M., van Lanschot, J. J. B., Steyerberg, E. W., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., Richel, D. J., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112088 · Cited by 5,521
Shapiro, J., van Lanschot, J. J. B., Hulshof, M. C. C. M., van Hagen, P., van Berge Henegouwen, M. I., Wijnhoven, B. P. L., van Laarhoven, H. W. M., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00040-6 · Cited by 2,565
Ychou, M., Boige, V., Pignon, J.-P., Conroy, T., Bouché, O., Lebreton, G., Ducourtieux, M., Bedenne, L., Fabre, J.-M., Saint-Aubert, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0597 · Cited by 2,086
Sjoquist, K. M., Burmeister, B. H., Smithers, B. M., Zalcberg, J. R., Simes, R. J., Barbour, A., & Gebski, V. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70142-5 · Cited by 1,647
Ando, N., Kato, H., Igaki, H., Shinoda, M., Ozawa, S., Shimizu, H., Nakamura, T., Yabusaki, H., Aoyama, N., Kurita, A., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2049-9 · Cited by 1,427
Metadata
- Authors
- Stahl, M., Walz, M. K., Stuschke, M., Lehmann, N., Meyer, H.-J., Riera-Knorrenschild, J., Langer, P., Engenhart-Cabillic, R., Bitzer, M., Königsrainer, A., Budach, W., & Wilke, H.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-02-20
- Volume
- 27
- Issue
- 6
- Pages
- 851-856
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2141666552
- Cited by
- 948
- References
- 22
- FWCI
- 55.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.